A nanotechnological approach in the current therapy of COVID-19: model drug oseltamivir-phosphate loaded PLGA nanoparticles targeted with spike protein binder …
Abstract Coronavirus disease 2019 (COVID-19) is today's most serious epidemic disease
threatening the human race. The initial therapeutic approach of SARS-CoV-2 disease is …
threatening the human race. The initial therapeutic approach of SARS-CoV-2 disease is …
Synthesis and applications of synthetic peptides
The synthesis and applications of the peptides are gaining increasing popularity as a result
of the developments in biotechnology and bioengineering areas and for a number of …
of the developments in biotechnology and bioengineering areas and for a number of …
[HTML][HTML] Adsorption and desorption of hydroxychloroquine onto sulphur doped graphene powders as a potential drug for COVID-19: physicochemical investigation …
Hydroxychloroquine (HCQ) is a very substantial drug active substance that was approved for
emergency use by the FDA during the peak of the COVID-19 pandemic due to its potent …
emergency use by the FDA during the peak of the COVID-19 pandemic due to its potent …
Angiotensin (1-7)-Stearic Acid Conjugate: Synthesis and Characterization
T Acar, B Uçar - Journal of the Turkish Chemical Society Section A …, 2022 - dergipark.org.tr
The novel coronavirus, SARS-CoV-2, broken out as the COVID-19 epidemic, is transported
into the cytoplasm by angiotensin-converting enzyme-2 (ACE2), a key protein of the renin …
into the cytoplasm by angiotensin-converting enzyme-2 (ACE2), a key protein of the renin …
[PDF][PDF] Development of lipopolysaccharide-polyoxidonium complexes and conjugates against the Q fever disease for application purpose of vaccine prototype
Coxiella burnetii is a Gram-negative bacteria that causes Q fever, a common zoonotic
disease worldwide. The Coxiella burnetii LPS (Lipopolysaccharides) membrane is a …
disease worldwide. The Coxiella burnetii LPS (Lipopolysaccharides) membrane is a …